TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE WITH HUMANIZED ANTI-TAC - AN ANTIBODY THAT BINDS TO THE INTERLEUKIN-2 RECEPTOR

被引：0
|
作者：
ANASETTI, C
HANSEN, JA
WALDMANN, TA
APPELBAUM, FR
DAVIS, J
DEEG, HJ
DONEY, K
MARTIN, PJ
NASH, R
STORB, R
SULLIVAN, KM
WITHERSPOON, RP
BINGER, MH
CHIZZONITE, R
HAKIMI, J
MOULD, D
SATOH, H
LIGHT, SE
机构：
[1] NIH, METAB BRANCH, BETHESDA, MD 20892 USA
[2] HOFFMANN LA ROCHE INC, NUTLEY, NJ 07110 USA
来源：
BLOOD | 1994年 / 84卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1320 / 1327
页数：8
相关论文
共 50 条
  • [21] MURINE GRAFT-VERSUS-HOST DISEASE ASSOCIATED WITH INTERLEUKIN-1 AND INTERLEUKIN-2 DEFECTS
    MENDES, ML
    RODE, H
    LAPP, WS
    TRANSPLANTATION PROCEEDINGS, 1985, 17 (01) : 541 - 543
  • [22] ANTI-TAC-H, A HUMANIZED ANTIBODY TO THE INTERLEUKIN-2 RECEPTOR, PROLONGS PRIMATE CARDIAC ALLOGRAFT SURVIVAL
    BROWN, PS
    PARENTEAU, GL
    DIRBAS, FM
    GARSIA, RJ
    GOLDMAN, CK
    BUKOWSKI, MA
    JUNGHANS, RP
    QUEEN, C
    HAKIMI, J
    BENJAMIN, WR
    CLARK, RE
    WALDMANN, TA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (07) : 2663 - 2667
  • [23] Graft-versus-host disease - Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin
    Khoury, H
    Kashyap, A
    Adkins, DR
    Brown, RA
    Miller, G
    Vij, R
    Westervelt, P
    Trinkaus, K
    Goodnough, LT
    Hayashi, RJ
    Parker, P
    Forman, SJ
    DiPersio, J
    BONE MARROW TRANSPLANTATION, 2001, 27 (10) : 1059 - 1064
  • [24] INTERLEUKIN-2 FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE AFTER HAPLOIDENTICAL MARROW TRANSPLANTATION
    PRZEPIORKA, D
    IPPOLITI, C
    KOBERDA, J
    CHAN, KW
    KHOURI, IF
    FISCHER, HE
    HUH, YO
    ESCUDIER, SM
    SEONG, D
    DAVIS, M
    GAJEWSKI, J
    VRIESENDORP, HM
    CHAMPLIN, RE
    TRANSPLANTATION, 1994, 58 (07) : 858 - 860
  • [25] TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE WITH METHYLPREDNISOLONE AND CYCLOSPORINE WITH OR WITHOUT AN ANTI-INTERLEUKIN-2 RECEPTOR MONOCLONAL-ANTIBODY - A MULTICENTER PHASE-III STUDY
    CAHN, JY
    BORDIGONI, P
    TIBERGHIEN, P
    MILPIED, N
    BRION, A
    WIDJENES, J
    LIOURE, B
    MICHEL, G
    BURDACH, S
    KOLB, HJ
    LINK, H
    VERNANT, JP
    IFRAH, N
    RACADOT, E
    HERVE, P
    EHNINGER, G
    TRANSPLANTATION, 1995, 60 (09) : 939 - 942
  • [26] TREATMENT OF CORTICOSTEROID RESISTANT ACUTE GRAFT-VERSUS-HOST DISEASE BY INVIVO ADMINISTRATION OF ANTI-INTERLEUKIN-2 RECEPTOR MONOCLONAL-ANTIBODY (B-B10)
    HERVE, P
    WIJDENES, J
    BERGERAT, JP
    BORDIGONI, P
    MILPIED, N
    CAHN, JY
    CLEMENT, C
    BELIARD, R
    MORELFOURRIER, B
    RACADOT, E
    TROUSSARD, X
    BENZLEMOINE, E
    GAUD, C
    LEGROS, M
    ATTAL, M
    KLOFT, M
    PETERS, A
    BLOOD, 1990, 75 (04) : 1017 - 1023
  • [27] Soluble interleukin-2 receptor concentration as a biochemical indicator for acute graft-versus-host disease after allogeneic bone marrow transplantation
    Mathias, C
    Mick, R
    Grupp, S
    Duffy, K
    Harris, F
    Laport, G
    Stadtmauer, E
    Luger, S
    Schuster, S
    Wasik, MA
    Porter, DL
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2000, 9 (03): : 393 - 400
  • [28] Serum levels of soluble interleukin-2 receptor after bone marrow transplantation: A true marker of acute graft-versus-host disease
    Kami, M
    Matsumura, T
    Tanaka, Y
    Mikami, Y
    Miyakoshi, S
    Ueyama, J
    Morinaga, S
    Mori, S
    Machida, U
    Kanda, Y
    Chiba, S
    Sakamaki, H
    Hirai, H
    Muto, Y
    LEUKEMIA & LYMPHOMA, 2000, 38 (5-6) : 533 - 540
  • [29] ANALYSIS OF HUMAN PRENATAL AND POSTNATAL THYMOCYTES WITH THE ANTI-TAC MONOCLONAL-ANTIBODY AND RECOMBINANT INTERLEUKIN-2
    PLUM, J
    DESMEDT, M
    THYMUS, 1987, 9 (03) : 149 - 158
  • [30] THE TREATMENT OF HAM/TSP PATIENTS WITH HUMANIZED ANTI-TAC ANTIBODY - PRELIMINARY IMMUNOLOGICAL STUDIES
    LEHKY, TJ
    LEVIN, M
    FLERLAGE, N
    WHITE, J
    FLEISHER, T
    MCFARLAND, H
    WALDMANN, T
    JACOBSON, S
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 (02): : 289 - 289
12345